Life-Span Study
Cross-source consensus on Life-Span Study from 1 sources and 4 claims.
1 sources · 4 claims
Comparisons
Evidence quality
Highlighted claims
- The Life-Span Study followed about 120,000 exposed people for more than 50 years. — Modelling lifespan reduction in an exogenous damage model of generic disease
- The Life-Span Study of Hiroshima and Nagasaki atom-bomb survivors was used as a long-term analogue for acute exogenous damage. — Modelling lifespan reduction in an exogenous damage model of generic disease
- The phenomenological model matched the Life-Span Study hazard structure as excess relative risk declining with age at exposure and linear in dose. — Modelling lifespan reduction in an exogenous damage model of generic disease
- The Life-Span Study estimate corresponding to alpha was consistent with the model alpha value. — Modelling lifespan reduction in an exogenous damage model of generic disease